These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22004944)

  • 41. The relative contributions of hostility and depressive symptoms to the income gradient in hospital-based incidence of ischaemic heart disease: 12-Year follow-up findings from the GLOBE study.
    Klabbers G; Bosma H; Van Lenthe FJ; Kempen GI; Van Eijk JT; Mackenbach JP
    Soc Sci Med; 2009 Oct; 69(8):1272-80. PubMed ID: 19713020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio.
    Pfaar O; Jung K; Wolf H; Decot E; Kleine-Tebbe J; Klimek L; Wüstenberg E
    Allergy; 2012 May; 67(5):630-7. PubMed ID: 22385366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific IgE positivity against inhalant allergens and development of autoimmune disease.
    Skaaby T; Husemoen LL; Thuesen BH; Fenger RV; Linneberg A
    Autoimmunity; 2015; 48(5):282-8. PubMed ID: 25600125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
    Nielsen NM; Frisch M; Rostgaard K; Wohlfahrt J; Hjalgrim H; Koch-Henriksen N; Melbye M; Westergaard T
    Mult Scler; 2008 Jul; 14(6):823-9. PubMed ID: 18573841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing prevalence despite decreasing incidence of ischaemic heart disease and myocardial infarction. A national register based perspective in Denmark, 1980-2009.
    Koch MB; Davidsen M; Andersen LV; Juel K; Jensen GB
    Eur J Prev Cardiol; 2015 Feb; 22(2):189-95. PubMed ID: 24165474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy.
    Rask C; Lund L; Lund G; Heydenreich B; Wurtzen P; Bellinghausen I; Saloga J; Lund K
    Clin Exp Allergy; 2012 Sep; 42(9):1356-68. PubMed ID: 22925322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis.
    Krishnan E; Lingala VB; Singh G
    Circulation; 2004 Sep; 110(13):1774-9. PubMed ID: 15381644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses.
    Matricardi PM; Kuna P; Panetta V; Wahn U; Narkus A
    J Allergy Clin Immunol; 2011 Oct; 128(4):791-799.e6. PubMed ID: 21620452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Birch-apple syndrome treated with birch pollen immunotherapy.
    Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G
    Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.
    Essers I; Stolwijk C; Boonen A; De Bruin ML; Bazelier MT; de Vries F; van Tubergen A
    Ann Rheum Dis; 2016 Jan; 75(1):203-9. PubMed ID: 25362044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imported fire ant field reaction and immunotherapy safety characteristics: the IFACS study.
    La Shell MS; Calabria CW; Quinn JM
    J Allergy Clin Immunol; 2010 Jun; 125(6):1294-9. PubMed ID: 20451988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study.
    Elmberg M; Hultcrantz R; Simard JF; Stål P; Pehrsson K; Askling J
    J Intern Med; 2012 Jul; 272(1):45-54. PubMed ID: 22026548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.
    Suadicani P; Hein HO; von Eyben FE; Gyntelberg F
    Metab Syndr Relat Disord; 2009 Apr; 7(2):97-104. PubMed ID: 19032035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.
    Gonzalez-Gay MA; Rubiera G; Piñeiro A; Garcia-Porrua C; Pego-Reigosa R; Gonzalez-Juanatey C; Sanchez-Andrade A; Llorca J
    J Rheumatol; 2005 Mar; 32(3):502-6. PubMed ID: 15742443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy.
    Hsu NM; Reisacher WR
    Int Forum Allergy Rhinol; 2012; 2(4):280-4. PubMed ID: 22434716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis.
    Troelsen LN; Garred P; Madsen HO; Jacobsen S
    Arthritis Rheum; 2007 Jan; 56(1):21-9. PubMed ID: 17195187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort.
    Jørgensen KT; Pedersen BV; Nielsen NM; Jacobsen S; Frisch M
    J Autoimmun; 2012 May; 38(2-3):J81-7. PubMed ID: 21813263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atopy and development of cancer: a population-based prospective study.
    Skaaby T; Nystrup Husemoen LL; Roswall N; Thuesen BH; Linneberg A
    J Allergy Clin Immunol Pract; 2014; 2(6):779-85. PubMed ID: 25439371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.